Trial Profile
A study of right ventricular structural morphology in relation to ventriculo-vascular coupling in patients with advanced pulmonary arterial hypertension undergoing treatment with treprostinil
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jun 2016
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society
- 18 Jan 2016 New trial record